A multicenter study of mutational profiling of Chinese ALK plus non-small cell lung cancer patients with acquired resistance to crizotinib using next generation sequencing

被引：0
|
作者：
Xu, C. [1 ]
Wang, W. [2 ]
Zhuang, W. [3 ]
Song, Z. [2 ]
Zhu, Y. [4 ]
Chen, G. [1 ]
Fang, M. [2 ]
Lv, T. [5 ]
Song, Y. [5 ]
机构：
[1] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Chemotherapy, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Med Thorac Oncol, Fuzhou, Fujian, Peoples R China
[4] Zhejiang Rongjun Hosp, Thorac Dis Ctr, Jiaxing, Peoples R China
[5] Jinling Hosp, Resp Med, Nanjing, Jiangsu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1394P
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Monitoring for and Characteristics of Crizotinib Progression: A Chart Review of ALK plus Non-Small Cell Lung Cancer Patients
    Bendaly, Edmond
    Dala, Anand
    Culver, Kenneth
    Galebach, Philip
    Bocharova, Iryna
    Foster, Rebekah
    Struebbe, Gero
    Guerin, Annie
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1163 - S1163
  • [22] BUDGET IMPACT ANALYSIS OF CRIZOTINIB TREATMENT IN ALK plus NON-SMALL CELL LUNG CANCER PATIENTS IN THAILAND
    Permsuwan, U.
    Petcharapiruch, S.
    Thongprasert, S.
    VALUE IN HEALTH, 2014, 17 (07) : A719 - A719
  • [23] ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
    McLeer-Florin, Anne
    Duruisseaux, Michael
    Pinsolle, Julian
    Dubourd, Sylvian
    Mondet, Julie
    Houlbracq, Mathilde Phillips
    Magnat, Nelly
    Faure, Julien
    Chatagnon, Amandine
    de Fraipont, Florence
    Levra, Matteo Giaj
    Toffart, Anne-Claire
    Ferretti, Gilbert
    Hainaut, Pierre
    Brarribilla, Elisabeth
    Moro-Sibilot, Denis
    Lantuejoul, Sylvie
    LUNG CANCER, 2018, 116 : 15 - 24
  • [24] ALK fusion variants detection by targeted RNA-next generation sequencing and clinical responses to crizotinib in ALK-positive non-small cell lung cancer
    Mc Leer, A.
    Duruisseaux, M.
    Pinsolle, J.
    Dubourg, S.
    Mondet, J.
    Phillips-Houlbracq, M.
    Magnat, N.
    Faure, J.
    Chatagnon, A.
    de Fraipont, F.
    Levra, M. Giaj
    Toffart, A. C.
    Ferretti, G.
    Brambilla, E.
    Hainaut, P.
    Moro-Sibilot, D.
    Lantuejoul, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer
    Kuang, Shelley
    Fung, Andrea S.
    Perdrizet, Kirstin A.
    Chen, Kaitlin
    Li, Janice J. N.
    Le, Lisa W.
    Cabanero, Michael
    Karsaneh, Ola Abu Al
    Tsao, Ming S.
    Morganstein, Josh
    Ranich, Laura
    Smith, Adam C.
    Wei, Cuihong
    Cheung, Carol
    Shepherd, Frances A.
    Liu, Geoffrey
    Bradbury, Penelope
    Pal, Prodipto
    Schwock, Joerg
    Sacher, Adrian G.
    Law, Jennifer H.
    Stockley, Tracy L.
    Leighl, Natasha B.
    CURRENT ONCOLOGY, 2022, 29 (07) : 4428 - 4437
  • [26] Clinical Next-Generation Sequencing in Patients with Non-Small Cell Lung Cancer
    Hagemann, Ian S.
    Devarakonda, Siddhartha
    Lockwood, Christina M.
    Spencer, David H.
    Guebert, Kalin
    Bredemeyer, Andrew J.
    Al-Kateb, Hussam
    Nguyen, TuDung T.
    Duncavage, Eric J.
    Cottrell, Catherine E.
    Kulkarni, Shashikant
    Nagarajan, Rakesh
    Seibert, Karen
    Baggstrom, Maria
    Waqar, Saiama N.
    Pfeifer, John D.
    Morgensztern, Daniel
    Govindan, Ramaswamy
    CANCER, 2015, 121 (04) : 631 - 639
  • [27] Next Generation Sequencing Reveals Genomic Heterogenity of ALK Fusion Breakpoints in Non-Small Cell Lung Cancer
    Rosenbaum, Jason N.
    Branson, Julie
    Cottrell, Catherine E.
    Pfeifer, John D.
    Kulkarm, Shashikant
    Duncavage, Eric J.
    MODERN PATHOLOGY, 2016, 29 : 481A - 482A
  • [28] Mutational profile of non-small cell lung cancer by targeted next-generation sequencing in the Mexican population
    Socca, Giovanny
    Alaez, Carmen
    Hernandez-Pedro, Norma
    Barrios-Bernal, Pedro A.
    Carrillo-Sanchez, Karol
    Aviles, Alejandro
    Arrieta, Oscar
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) : S24 - S25
  • [29] The correlation between Crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Song, Yong
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [30] The correlation between crizotinib efficacy and molecular heterogeneity by next-generation sequencing in non-small cell lung cancer
    Lv, Tangfeng
    Zou, Qian
    Song, Zhengbo
    Liu, Hongbing
    Wang, Qiming
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2018, 10 (05) : 2948 - +
12345